Translate the text from English to Welsh.



 
The COVID\-19 vaccination programme in Wales is now inviting individuals in cohort 6 of the Joint Committee on Vaccination and Immunisation (JCVI) priority list. These are the individuals aged 16 years to 64 years with underlying health conditions which put them at higher risk of serious disease and mortality. 


There have been no changes to cohort 6 of the prioritisation list, but I wanted to provide Members with clarification on how severe asthma has been defined for inclusion this cohort. 


The Welsh Government, like the other UK nations, is following the advice of the JCVI who, since December 2020, has recommended that only those with severe asthma are at increased risk from COVID\-19\. Individuals with mild to moderate asthma are not at increased risk of severe outcomes with COVID\-19 and not recommended for vaccination at this time by JCVI. 


Only those with severe asthma are to be included in cohort 6 and they are defined as those with regular use of oral corticosteroids (at least three prescriptions in the past two years) or previously requiring hospital admission for an exacerbation of asthma. There is no time limit on when hospital admission occurred.


The Welsh Government wrote to primary care providers on 5 March 2021 to provide clarification and guidance on a number of groups in cohort 6, including asthma. This letter is being published alongside this written statement.


We have given a commitment, subject to supply, to offer vaccination all those in groups 5\-9 by mid\-April and those in groups 5 and 6 are currently being invited for their appointments.





### Documents


* #### Annex,
 file type: pdf, file size: 307 KB



307 KB







Translation:


 
Mae rhaglen frechu COVID\-19 yng Nghymru yn awr yn gwahodd unigolion yng ngrŵp 6 ar restr blaenoriaeth y Cyd\-bwyllgor ar Imiwneiddio a Brechu. Y rhain yw’r unigolion 16 i 64 oed sydd â chyflyrau iechyd sy’n bodoli eisoes ac sy’n eu rhoi mewn mwy o berygl o salwch difrifol a marwolaeth. 


Ni fu unrhyw newidiadau i grŵp 6 ar y rhestr flaenoriaeth, ond roeddwn eisiau esbonio i’r Aelodau sut y diffiniwyd asthma difrifol ar gyfer ei gynnwys yn y grŵp hwn. 


Mae Llywodraeth Cymru, fel gwledydd eraill y DU, yn dilyn cyngor y Cyd\-bwyllgor ar Imiwneiddio a Brechu sydd, ers mis Rhagfyr 2020, wedi argymell mai dim ond pobl ag  asthma difrifol sy’n wynebu risg uwch o ganlyniad i COVID\-19\. Nid yw unigolion ag asthma ysgafn i gymedrol yn wynebu risg uwch o ganlyniadau difrifol o ganlyniad i COVID\-19 ac nid yw’r Cyd\-bwyllgor ar Imiwneiddio a Brechu yn argymell y dylent gael y brechlyn ar hyn o bryd. 


Dim ond pobl gydag asthma difrifol sy’n cael eu cynnwys yng ngrŵp 6 ac mae’r bobl hyn wedi’u diffinio fel pobl sy’n defnyddio corticosteroidau drwy’r geg (o leiaf dri phresgripsiwn yn y ddwy flynedd ddiwethaf) neu sydd wedi gorfod mynd i’r ysbyty oherwydd gwaethygiad yr asthma. Does dim cyfyngiad o ran amser ar dderbyn i’r ysbyty.


Ysgrifennodd Llywodraeth Cymru at ddarparwyr gofal sylfaenol ar 5 Mawrth 2021 i roi esboniad ac arweiniad iddynt ar nifer o grwpiau o fewn grŵp 6, gan gynnwys asthma. Caiff y llythyr ei gyhoeddi ochr yn ochr â’r datganiad ysgrifenedig hwn.


Yn amodol ar gyflenwad, rydym wedi ymrwymo i gynnig y brechlyn i bawb yng ngrwpiau 5\-9 erbyn canol mis Ebrill ac mae’r bobl yng ngrwpiau blaenoriaeth 5 a 6 yn cael eu gwahodd i ddod i apwyntiadau ar hyn o bryd.





### Dogfennau


* #### Atodiad,
 math o ffeil: pdf, maint ffeil: 312 KB



312 KB